The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 135.00
Bid: 134.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.493%)
Open: 135.00
High: 135.00
Low: 135.00
Prev. Close: 135.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

26 Jan 2023 07:00

RNS Number : 8923N
Eurocell plc
26 January 2023
 

26 January 2023

EUROCELL PLC

("Eurocell" or the "Group")

Year End Trading Update

 

Eurocell plc, the market leading, vertically integrated UK manufacturer, recycler and distributor of innovative window, door and roofline PVC products, provides the following update for the for the year ended 31 December 2022.

 

Trading Performance

Group sales for the year ended 31 December 2022 were £384 million, up 12% compared to 2021. Divisional growth rates were as follows:

 

Sales growth vs 2021

6 months to 30 June 2022

6 months to 31 Dec 2022

12 months to 31 Dec 2022

Total Group

13%

11%

12%

Profiles Division

17%

13%

15%

Building Plastics Division

11%

9%

10%

 

Following a strong first six months of the year, new build, large contract and RMI project work continued to be robust throughout the second half of 2022. This was offset by the impact of the previously reported cyber incident and a slowdown in smaller discretionary RMI work experienced by our branch network and trade fabricators in H2, albeit against an exceptionally strong comparative period. After a period of very strong demand, we believe the market is now returning to pre-pandemic norms.

 

Price was the driver of sales growth in 2022. Whilst we continue to offset input cost inflation with selling price increases and surcharges, we experienced margin pressure in the second half, reflecting a lag on implementing some selling price increases. However, the cost of key raw materials does now appear to be stabilising, and in some cases beginning to fall.

 

Cyber Insurance Claim

As reported at the Half Year, we experienced a cyber incident towards the end of July, which resulted in some temporary disruption. The incident was efficiently resolved, with the business remaining operational throughout and trading normally from mid-August. We have now partially resolved our cyber insurance claim and expect to recognise compensation in excess of £1 million as an underlying item in our 2022 financial statements, primarily for business interruption. Work is ongoing with the insurer to resolve the remaining aspects of the claim.

 

Disposal of Security Hardware

To further streamline our business, in December 2022 we sold the trade and assets of Security Hardware, a supplier of window locks, hardware and spares to the RMI market with annual third-party sales of c.£3 million, to UAP Limited, a UK-based door hardware supplier. Going forward, UAP will supply hardware to all our branches.

 

As a result of the sale, we expect to report an overall loss from discontinued operations in the 2022 financial statements of c.£2 million. This incorporates a trading loss for the period of c.£1 million (inclusive of costs incurred to prepare the business for sale), as well as the sale proceeds and associated asset impairments.

 

2022 Financial Results

Reflecting the factors described above, we expect underlying profit before tax from continuing operations for the year ended 31 December 2022 to be in line with market expectations, with the trading loss at Security Hardware of c.£1 million separately classified within discontinued operations.

 

Outlook and Cost Saving Programme

We are mindful of the uncertain macro-economic background and its impact on our markets. The Construction Product Association's latest forecast, published in November 2022, predicts declines in both the RMI and new build markets of 9% for 2023, before recovering in 2024, and we have experienced some recent weakness in those sectors.

 

In anticipation of weaker markets in 2023, we completed a restructuring programme in Q4 2022, which along with other cost saving measures, will reduce operating costs by approximately £5 million per annum from the start of 2023. A charge of c.£2 million will be included as a non-underlying item in our 2022 financial statements in respect of the programme. We also intend to temporarily pause our branch opening programme until the economic outlook is clearer.

 

However, we continue to take market share and have increased the run rate on new fabricator account acquisitions, with our pipeline of other potential new fabricator customers remaining healthy. Market share gains are further supported by the impact of maturing branches and a widening product range, all underpinned by very high product availability and increasingly efficient operations.

 

Our debt is low, our balance sheet is strong and we remain confident of continuing to outperform our markets.

 

Notice of Results

We expect to publish our results for the year ending 31 December 2022 on 16 March 2023, at which time we will provide further guidance on the year ahead.

 

 

Enquiries:

Eurocell plc

 

Mark Kelly, Chief Executive Officer

+44 (0) 1773 842 105

Michael Scott, Chief Financial Officer

+44 (0) 1773 842 140

 

 

Teneo

 

Ben Foster

+44 (0) 777 624 0806

Camilla Cunningham

+44 (0) 746 498 2426

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKELFLXFLBBBX
Date   Source Headline
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSDirector/PDMR Shareholding
19th Apr 20247:00 amRNSPublication of 2023 Annual Report & Notice of AGM
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:01 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
26th Mar 20244:30 pmRNSHolding(s) in Company
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSInvestor Presentation
20th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSBlock listing Interim Review
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20247:00 amRNSTransaction in Own Shares
28th Feb 20247:00 amRNSTransaction in Own Shares
27th Feb 20247:00 amRNSTransaction in Own Shares
23rd Feb 20247:00 amRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSTransaction in Own Shares
21st Feb 20247:00 amRNSTransaction in Own Shares
20th Feb 20247:00 amRNSTransaction in Own Shares
19th Feb 20247:00 amRNSTransaction in Own Shares
16th Feb 20247:00 amRNSTransaction in Own Shares
15th Feb 20246:00 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTransaction in Own Shares
14th Feb 20247:00 amRNSTransaction in Own Shares
13th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 20247:00 amRNSTransaction in Own Shares
8th Feb 20247:00 amRNSTransaction in Own Shares
7th Feb 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.